EDIT
Companies
NASDAQ
Editas Medicine Inc.
Health Care
$2.14
+$1.07 (+84.25%)
Price Chart
Overview
About EDIT
unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Market Cap
$435.9M
Volume
3.9M
Avg. Volume
6.0M
P/E Ratio
-0.41659576
Dividend Yield
0.00%
Employees
261.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.51
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EDIT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$435.9M
Volume3.9M
P/E Ratio-0.42
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 6, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025